Mr Winzer has served as executive vice president and CFO of Avalon Pharmaceuticals since July 2007. Dr Keith assumed the position of president and COO of Panacea Pharmaceuticals in 2006. Mr Jorden was most recently with Morgan Stanley’s private wealth management group where he was responsible for equity portfolio management for high net worth individuals.
Martin Rosendale, CEO of Cytomedix, said: “I am thrilled at the addition of these gentlemen to the board. They possess, and offer to the company, crucially relevant skills to provide the strategic oversight and guidance at this exciting time in the company’s history. Their combined skills in the areas of medicine, business development, product commercialization, strategic planning and investor relations will serve us well as we seek to implement our strategy and grow the company.”